Revance Therapeutics shares owned by Quinn Opportunity Partners
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Quinn Opportunity Partners
from 13F filings
Historical chart of Quinn Opportunity Partners investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Quinn Opportunity Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Quinn Opportunity Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $26k | 10k | 2.57 |
2024-03-31 | $49k | 10k | 4.92 |
2023-12-31 | $88k | 10k | 8.79 |
2020-06-30 | $371k | 15k | 24.41 |
2020-03-31 | $225k | 15k | 14.80 |
2019-12-31 | $921k | 57k | 16.22 |
2019-09-30 | $694k | 53k | 13.00 |
2019-06-30 | $683k | 53k | 12.97 |
2019-03-31 | $893k | 57k | 15.76 |
2018-12-31 | $1.1M | 57k | 20.13 |
2018-09-30 | $1.5M | 59k | 24.85 |
2018-06-30 | $280k | 9.1k | 30.77 |
2018-03-31 | $280k | 9.1k | 30.77 |
2017-12-31 | $325k | 9.1k | 35.71 |
More positions owned by Quinn Opportunity Partners
View all positions for Quinn Opportunity Partners